Britain’s exit from the EU offers opportunities for the UK animal health market, including further possibilities for animal medicine businesses to thrive, according to NOAH.

brexit-puzzle_EU_Fotolia_PixelblissThe organisation released a statement outlining its views on the day PM Theresa May formally triggered Article 50 to enable Brexit negotiations to begin.

NOAH says the triggering of Article 50 should mark an increase in certainty and stability for NOAH member businesses. However, it added: “it is vital negotiations over our exit allow for the animal health sector to continue making its important contribution to UK’s economy, food security and society – and enable this dynamic sector to grow.”


NOAH chair Cat Sayer said: “Exit from the EU offers opportunities for our vibrant and innovative UK animal health market, including further possibilities for animal medicines businesses to thrive.

“The UK is in a strong position to be a global centre of excellence for animal health, supporting innovative product developments with a regulatory model that assists both local and international trade.

“It is good to see science, research and innovation included as a key pillar in the Government’s Industrial Strategy Green Paper. Our sector, with its important role in food production and societal wellbeing, as well as the support it gives to the economy, is an important part of that.

“The UK’s EU exit must be achieved in a manner that will allow the opportunities it presents to our sector to come to fruition.”

NOAH vision

NOAH said its vision post-Brexit was for an environment that delivered a thriving animal medicines sector:

  • Supporting trade and innovation
  • Safeguarding animal health, welfare, public health and food safety; ensuring UK veterinarians and animal keepers continue to have access to a wide range of appropriate veterinary medicines
  • Businesses have access to skilled staff– a workforce with the appropriate skills they need
  • Product research and development is incentivised within a world-leading regulatory system
  • Companies are encouraged to do business in the UK as unnecessary regulatory burdens are recognised and removed
  • Transitional arrangements to support business continuity post-EU exit are built, utilising links with specialist EU infrastructure where necessary
View your activity >

Leave a Reply

Be the First to Comment!

Notify of


related content

A vet and her colleagues are taking on a walk for charity after being diagnosed with breast cancer.

3 mins

The RCVS disciplinary committee has accepted a form of undertakings from Worcester-based vet David John Bibby Denny, who has agreed to remove himself from the register and never apply to be restored.

3 mins

A “disproportionately high” number of vets reported to have experienced adverse events from the use of authorised veterinary medicines were female, according to the latest pharmacovigilance report from the VMD.

5 mins

Reducing antibiotic consumption in animals may not have any great benefits to human health, according to new research.

5 mins

Specialist veterinary virology, serology and DNA diagnostics company Biobest Laboratories is offering a new PCR test service for porcine reproductive and respiratory syndrome virus (PRRSV).

3 mins

Equine vets wanting to enhance their orthopaedic skills can do so at a CPD event taking place later this year.

3 mins